Annals of Oncology Research and Therapy

: 2021  |  Volume : 1  |  Issue : 1  |  Page : 1--2

A new beginning

Amal Chandra Kataki 
 Department of Gynecological Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India

Correspondence Address:
Dr. Amal Chandra Kataki
Dr. B Borooah Cancer Institute, Guwahati - 781 016, Assam

How to cite this article:
Kataki AC. A new beginning.Ann Oncol Res Ther 2021;1:1-2

How to cite this URL:
Kataki AC. A new beginning. Ann Oncol Res Ther [serial online] 2021 [cited 2022 Jun 25 ];1:1-2
Available from:

Full Text

Dr. Bhubaneswar Borooah Cancer Institute has launched its official publication the Annals of Oncology Research and Therapy (AORT). As the founder Editor In-Chief of the journal, it is a great responsibility to reach out to leading researchers on cancer within the country and also outside, and then seek support for the journal. The biggest challenge is to publish the first issue with limited articles on hand and still maintain high scientific rigor. Our editorial board members and Associate Editor have been aptly handling manuscripts and sending them out for external review. This process ensures that the research work submitted for publication at AORT is vetted for its quality.

One review article on intensification of adjuvant treatment in early oral cancers noted that treatment intensification may be necessary for almost a fourth of patients with clinical, early-stage disease in the presence of various adverse risk features. It further, advocates randomized trials, risk assessment models, and nomograms in this area. Another article presents a comprehensive review of the automated breast cancer detection system from fine needle cytology aspiration images. The authors of the review conclude that deep learning-based methods are more suitable for real-life problems since they can extract more complex features and can give a highly satisfactory result. In the future artificial intelligence holds big promise for radiology and cytology reporting.

One original article which was an observational study looks at the association of body mass index (BMI) with clinicopathological characteristics and hormone receptor status in breast cancer patients. Researchers of this study aimed to analyze the association of BMI with menopausal status, tumor characteristics, and hormone receptor status in breast cancer patients. The study revealed that BMI has a significant association with the menopausal state but lack significant association with tumor size, stage, grade, and lymph node status in both pre- and post-menopausal patients. The frequency of expression of estrogen receptor/progesterone receptor was the same as reported in the literature although expression of human epidermal growth factor receptor 2 (HER2)/neu was higher in postmenopausal women, HER2/neu expression, in addition, showed statistically significant association with age at diagnosis.

A single-center retrospective study on postmastectomy chest wall irradiation with electron beam technique to treat dermal lymphatics and subcutaneous tissue using 6–8 MeV electrons with reduction in pulmonary and cardiac doses. The study concludes postmastectomy radiation using an enface chest wall electron field with three-dimensional conformal radiation therapy planning offers a suitable alternative for the photon field in carefully selected cases. The advantage of the electron field is the better sparing of deeper structures, especially cardia in left-sided postmastectomy irradiation with equivalent local control and survival.

An original article to review on posthysterectomy malignant pelvic masses in women who had undergone hysterectomy outside for benign indications has been published. The study found that, the complete evaluation and thorough work up are crucial steps in the management of women presenting with gynecological symptoms keeping in mind the possibility of malignancy so as not to deal with such long-standing recurrent pelvic disease thereafter.

A hospital-based cancer survival study among men of North East (NE) India found that 5-year overall survival in hospital settings for cancers of liver, pancreas, and lung, respectively was poor (0%–2.6%). This study of relatively poor cancer survival in NE India replicates the findings of the National Center for Disease Informatics and Research under the Indian Council of Medical Research.

In the forthcoming volume and issues of AORT, we hope to publish high-quality peer-reviewed research. It is a humble beginning in the pursuit of scientific developments in the field of oncology, from basic research to translational ones. I express my gratitude to all the authors and members of the editorial board of AORT. The voyage of this oncology journal has begun and we hope it travels far and wide!